Three-week hypofractionated radiotherapy in early glottic cancer—a single institution retrospective study

BACKGROUND: Radiotherapy is a standard treatment option for early glottic carcinoma (stage I and II) with a fraction size of 2–2.2 Gy over 5–7 weeks. This study evaluates the outcome and prognostic factors of a 3-week hypofractionated treatment in early glottic malignancy. MATERIALS AND METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudha, Arun Sankar, Kumar, Ravikumar Rejnish, Anjanappa, Milan, Kainickal, Cessal Thomas, Mathew, Aleyamma, Kunnambath, Ramadas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300409/
https://www.ncbi.nlm.nih.gov/pubmed/35919227
http://dx.doi.org/10.3332/ecancer.2022.1381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300409/
https://www.ncbi.nlm.nih.gov/pubmed/35919227
http://dx.doi.org/10.3332/ecancer.2022.1381

Ejemplares similares